4Am J. Management of Malignant Pleural Effusions [J]. Respir Crit Care Med, 2000, 162(5):1987-2001.
5Sahn SA. Management of malignant pleural effuSions [J]. Monaldi Arch Chest Dis, 2001, 56(5):394-399.
6Sahin U, Unlu M. The Value of small-bore catheter thoracostomy in the treatment of malignant pleural effusions [J]. Respiration,2001, 68(5): 501-505.
7Katano M, Morisaki T. The past, the present and future of the OK-432 therapy for patients with malignant effusions [J]. Anticancer Res, 1998, 18(5D):3917-3925.
8Cardillo C, Facciolo F, Carbone L, et al. Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions [J]. Eur J Cardiothorac Surg, 2002, 21(2):302-305.
9Brant A, Eaton T. Serious complications with talc slurry pleurodesis[J]. Respirology, 2001, 6(3):181 - 185.
10Schulze M, Boehle AS, Kurdow R, et al. Effective treatment of malignant pleural effusion by minimal invasive thoracic surgery:thoracoscopic talc pleurodesis and pleu-roperitoneal shunts in 101 patients[J]. Ann ThoracSurg, 2001, 71(6):1809-1812.
3Mallika,Tewari,Satyajit. Assessment of predictive mark- ers of response to neoadjuvant chemotherapy in breast cancer[J]. Asian Journal of Surgery/Asian Surgical Asso- ciation, 2010,33 (4) : 156-167.
4Abhay Kumar,Singh,Rajinder,Parshad,Shweta. Prognos- tic significance of cyclooxygenase-2 and response to chemotherapy in invasive ductal breast carcinoma pa- tients by real time surface plasmon resonance analysis[J]. DNA and Cell Biology, 2011,30(10) : 801-807.
